Therapeutic uses of penicillin g
I'll start by reading the medical library skill before answering.
Reading File
Now let me search the medical library and PubMed in parallel.
Finding Sources
Finding Sources
Searching PubMed
"penicillin G" AND therapeutic uses
Now let me read the key textbook sections in parallel for comprehensive coverage.
Reading File
Reading File
Reading File
Let me now read the therapeutic uses section from Goodman & Gilman's which is the most authoritative pharmacology text, and also the Harriet Lane dosing for key indications.
Reading File
Reading File
The Goodman & Gilman section was truncated. Let me get the therapeutic uses section directly.
Reading File
Reading File
I have excellent data. Let me read the remaining therapeutic uses section from Goodman & Gilman's to complete the picture.
Reading File
I now have comprehensive data from multiple authoritative textbooks. Here is the complete answer:
Therapeutic Uses of Penicillin G (Benzylpenicillin)
Penicillin G is a natural penicillin with a narrow but clinically important spectrum. It is active primarily against gram-positive bacteria, most anaerobes, and several spirochetes. It is acid-labile (destroyed by stomach acid), so it is given parenterally (IV or IM) for systemic infections; oral use is not practical. It is 60% protein-bound and has a very short half-life (~30 minutes), so it must be given frequently or as a repository (depot) preparation.
1. Streptococcal Infections
a) Group A Streptococcus (S. pyogenes)
Penicillin G remains the drug of choice - no penicillin-resistant Group A streptococcal isolates have ever been documented.
- Pharyngitis: preferred oral therapy is penicillin V (more acid-stable), 500 mg twice daily for 10 days - penicillin treatment reduces risk of subsequent acute rheumatic fever.
- Erysipelas and cellulitis: oral penicillin V is effective.
- Necrotizing fasciitis/toxic shock: penicillin G + clindamycin (clindamycin reduces streptococcal toxin production).
b) Viridans Group Streptococcal Endocarditis (native valve)
- Highly penicillin-susceptible organisms: 12-20 million units/day IV for 4 weeks (or 2 weeks with gentamicin added).
- Quantitative sensitivity testing guides dosing and combination therapy decisions.
c) Group B Streptococcus (S. agalactiae)
- Neonatal meningitis and severe GBS infection: penicillin G is the drug of choice.
- Neonatal GBS meningitis: up to 450,000-500,000 units/kg/day divided Q4-6h.
2. Pneumococcal (S. pneumoniae) Infections
- Drug of choice for penicillin-sensitive strains - regimens of 12-24 million units/day IV for 7-14 days.
- For pneumococcal meningitis: due to risk of β-lactam resistance, empiric therapy should use vancomycin + a 3rd-generation cephalosporin until sensitivity is confirmed; dexamethasone given before or with antibiotics improves outcomes.
- Resistance is increasing (especially in children), so susceptibility testing is essential.
(Goodman & Gilman's The Pharmacological Basis of Therapeutics, p. 1170-1171)
3. Syphilis (Treponema pallidum)
Penicillin G is the only proven therapy for all stages of syphilis. There are no proven alternatives in pregnancy - penicillin-allergic pregnant women must undergo acute desensitization.
| Stage | Preparation | Dose |
|---|---|---|
| Primary, secondary, early latent (<1 yr) | Benzathine penicillin G IM | 2.4 million units × 1 (or 1-3 weekly doses) |
| Late latent or unknown duration | Benzathine penicillin G IM | 2.4 million units Q7 days × 3 doses |
| Neurosyphilis / cardiovascular syphilis | Aqueous penicillin G IV | 18-24 million units/day × 10-14 days |
| Congenital syphilis (neonate) | Aqueous penicillin G IV | 100,000-150,000 units/kg/day × 10 days |
- Jarisch-Herxheimer reaction may occur in secondary syphilis (fever, chills, myalgias within hours of first dose due to spirochetal antigen release) - manage with antipyretics; do not stop therapy.
(Harriet Lane Handbook, 23rd ed.; Goodman & Gilman's, p. 1171)
4. Meningococcal Infections (Neisseria meningitidis)
- Penicillin G is an alternative to 3rd-generation cephalosporins for confirmed sensitive meningococcal infections (N. meningitidis remains highly sensitive in most cases).
- High-dose IV penicillin G is required.
- Does not eliminate the meningococcal carrier state, so it is not used for chemoprophylaxis after exposure.
5. Anaerobic Infections
- Pulmonary and periodontal infections (mild-moderate): penicillin G or V 250 mg QID orally.
- Severe infections: 12-24 million units IV daily.
- Clostridial gas gangrene: penicillin G 12-24 million units/day IV plus clindamycin, combined with surgical debridement.
- Tetanus (C. tetani): antibiotics have minimal effect on outcome; debridement and tetanus immune globulin are the mainstays.
- Note: Bacteroides fragilis is resistant to penicillins (produces a β-lactamase/cephalosporinase).
6. Actinomycosis (Actinomyces israelii)
- Penicillin G is the drug of choice for all forms.
- Dose: 18-24 million units IV/day for 6 weeks, often followed by oral therapy.
- Surgical drainage or excision may be required.
7. Listeria monocytogenes Infections
- Ampicillin or penicillin G are drugs of choice (gentamicin added for immunosuppressed patients with meningitis).
- Recommended dose: 18-24 million units/day parenterally for at least 2 weeks; endocarditis requires at least 4 weeks.
8. Leptospirosis
- Penicillin G is susceptible and used for leptospirosis (Leptospira spp.).
9. Pasteurella multocida (Animal Bite Wounds)
- Susceptible to penicillin G and ampicillin.
- Note: resistant to penicillinase-resistant penicillins (oxacillin, dicloxacillin) and first-generation cephalosporins.
10. Rat-Bite Fever (Streptobacillus moniliformis)
- Penicillin G is effective against S. moniliformis.
Prophylactic Uses
| Indication | Regimen |
|---|---|
| Rheumatic fever prevention | Oral penicillin V/G 200,000 units Q12h, OR benzathine penicillin G 1.2 million units IM once monthly |
| Asplenia (functional/anatomic) | Penicillin V prophylaxis (plus vaccination against encapsulated organisms) |
(Goodman & Gilman's The Pharmacological Basis of Therapeutics, p. 1171)
Preparations Summary
| Form | Route | Duration | Key Use |
|---|---|---|---|
| Aqueous penicillin G (K+ or Na+ salt) | IV / IM | t½ ~30 min | Acute/severe infections - meningitis, gas gangrene, neurosyphilis, endocarditis |
| Penicillin G procaine | IM only | ~24h (once daily) | Moderate infections |
| Penicillin G benzathine (Bicillin L-A) | IM only | ~26 days | Syphilis, RF prophylaxis, GAS pharyngitis |
| Bicillin C-R (benzathine + procaine) | IM only | Intermediate | GAS infections in children |
Important: Repository forms (benzathine, procaine) must never be given IV - cardiac arrest and death can result.
What Penicillin G Does NOT Cover
- Most S. aureus (>90% resistant via β-lactamase)
- MRSA / MRSE (all β-lactams ineffective)
- Most gram-negative rods (poor gram-negative penetration)
- Bacteroides fragilis
- Atypicals (Mycoplasma, Chlamydia, Legionella)
- Fungi, viruses, parasites
(Sources: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14e, pp. 1170-1171; The Harriet Lane Handbook 23e; Jawetz Medical Microbiology 28e)
Recent evidence note: A 2024 systematic review/meta-analysis (PMID 38661311) on neurosyphilis confirms penicillin G remains the standard but reviews alternatives for penicillin-allergic patients - no major change to established regimens. A 2025 meta-analysis (PMID 41671009) confirms benzathine penicillin G treatment of gestational syphilis in the third trimester significantly reduces congenital syphilis incidence.
This is a shared conversation. Sign in to Orris to start your own chat.